Maternal metabolic conditions identified by newborn screening

Rebecca Sponberg1, Rebekah Barrick1, Kathryn Gasperian1

  • 1Children's Health of Orange County (CHOC), part of Rady Children's Health, Orange, CA, USA.

PubMed

Insights

Newborn screening (NBS) can identify maternal conditions, preventing serious health issues for infants. This review highlights 14 maternal conditions discovered through NBS, aiding future screening programs.

Area of Science:

  • Biochemistry
  • Genetics
  • Public Health

Background:

  • Newborn screening (NBS) is a vital public health initiative for early detection of treatable infant disorders.
  • Expanded NBS using tandem mass spectrometry has increased the detection of inborn errors of metabolism (IEM).
  • Case reports revealed maternal IEM or vitamin deficiencies influencing infant NBS results.

Purpose of the Study:

  • To review maternal conditions identified through NBS.
  • To define "maternal condition" in the context of NBS.
  • To provide insights for countries implementing expanded NBS.

Main Methods:

  • Conducted a PubMed literature search.
  • Identified and reviewed case reports of maternal conditions linked to abnormal NBS results.
  • Focused on conditions where the mother is affected and the child is unaffected or a carrier.

Main Results:

  • Identified 14 distinct maternal conditions diagnosed via NBS.
  • Detailed the biochemical and genetic findings for these maternal conditions.
  • Confirmed that maternal conditions can manifest through abnormal infant NBS results.

Conclusions:

  • NBS can serve as a crucial tool for identifying previously undiagnosed maternal conditions.
  • This review offers valuable information for metabolic providers and countries developing NBS programs.
  • Early identification of maternal conditions through NBS can prevent adverse outcomes for both mother and child.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K